Summary – Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Drug
-
-
AgrochemicalsAlembic Pharma
Alembic gets USFDA nod for generic hypertension Selexipag tablets
by adminby adminSummary : Alembic said it has so far received 15 product approvals this year. Alembic Pharma received approval from the US health…
-
Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…
-
AgrochemicalsVyera Pharma
Vyera Pharma Agreed to Pay Up $ 40 settlement for Daraprim
by adminby adminSynopsis : Vyera Pharmaceuticals has agreed to pay up to $40 million to settle charges that it engaged in anticompetitive practices to…
-
Summary- The Indian Pharmacopoeia Commission (IPC) has added 9 new IP impurities standards which includes Bromhexine Hydrochloride Impurity C, Cabergoline Impurity A,…
-
AgrochemicalsBayer
Bayer’s Nubeqa Ameliorate Endurance in Prostate Cancer Clinical Trial
by adminby adminSummary – Bayer’s blockbuster hopes for Nubeqa just got a little brighter, thanks to a phase 3 trial win that could result…
-
Agrochemicals
EUSA Pharma will be Acquired by Italian Firm Recordati for €750 Million Will Boost Rare Disease Offering
by adminby adminItalian drugmaker Recordati has agreed on a price for six-year-old EUSA Pharma. The Milan-based firm will pay €750m ($845 million) for EUSA’s…
-
Agrochemicals
The USFDA Grants Orphan Drug Designation to CT120 a Novel CAR T-Cell Therapy of IASO Biotherapeutics for Acute Lymphoblastic Leukemia
by adminby adminKEYPOINTS: The FDA has granted orphan drug designation (ODD) to CT120 for the treatment of acute lymphoblastic leukemia, a novel chimeric antigen…
-
Agrochemicals
BioMarin`s VOXZOGO (Vosoritide) becomes the First U.S.FDA-approved Drug Therapy for Dwarfism.
by adminby adminSynopsis: BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (Vosoritide) for Injection, indicated…
-
CompaniesPfizerTofacitinib
Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
by adminby adminAbstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…